December 13, 2022

Immunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL

December 13, 2022

Blinatumomab regimen may lead to ‘diminishing use of transplant’ for B-ALL subgroup (study E1910)

December 13, 2022

Press Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)

December 11, 2022

Press Release: A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressive—yet highly curable—acute promyelocytic leukemia (APL)

October 20, 2022

Press Release: ECOG-ACRIN taps the University of Pennsylvania’s Selina Luger to lead its Leukemia Committee

October 13, 2022

The September/October 2022 News from ECOG-ACRIN blog is now available

July 14, 2022

Media Advisory: Blood publishes long-term outcomes of patients with CLL in the practice-changing E1912 trial

June 28, 2022

The Summer 2022 advocacy blog, Considering Clinical Trials, is now available

February 28, 2022

E1912 and other trials spur emergence of small molecule-inhibitor therapies for chronic lymphocytic leukemia

ECOG-ACRIN Cancer Research Group